These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 16841178)

  • 1. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiles of progestogen effects in the postmenopausal breast.
    Wood CE; Register TC; Cline JM
    Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model.
    Wood CE; Sitruk-Ware RL; Tsong YY; Register TC; Lees CJ; Cline JM
    Menopause; 2007; 14(4):639-47. PubMed ID: 17224855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of oral conjugated equine estrogens and micronized 17beta-estradiol on breast proliferation: a retrospective analysis.
    Wood CE; Clarkson TB; Chen H; Veenstra TD; Xu X; Scott L; Cline JM
    Menopause; 2008; 15(5):890-8. PubMed ID: 18520696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy effects on social behavior and activity levels of surgically postmenopausal cynomolgus monkeys.
    Shively CA; Wood CE; Register TC; Willard SL; Lees CJ; Chen H; Sitruk-Ware RL; Tsong YY; Cline JM
    Psychoneuroendocrinology; 2007; 32(8-10):981-90. PubMed ID: 17768011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized progesterone and its impact on the endometrium and breast vs. progestogens.
    Gompel A
    Climacteric; 2012 Apr; 15 Suppl 1():18-25. PubMed ID: 22432812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
    Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
    Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
    Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
    Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells.
    Mrusek S; Classen-Linke I; Vloet A; Beier HM; Krusche CA
    Mol Cell Endocrinol; 2005 May; 235(1-2):39-50. PubMed ID: 15866426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A; Bonanni B; Baglietto L; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Robertson C; Marinucci I; Mariette F; Sandri MT; Daldoss C; Bianco V; Buttarelli M; Cazzaniga M; Franchi D; Cassano E; Omodei U
    Clin Cancer Res; 2004 Jul; 10(13):4389-97. PubMed ID: 15240527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
    Purmonen S; Manninen T; Pennanen P; Ylikomi T
    Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
    Werner HM; Franke HR; Vermes I
    Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
    Schneck H; Ruan X; Seeger H; Cahill MA; Fehm T; Mueck AO; Neubauer H
    Gynecol Endocrinol; 2013 Feb; 29(2):160-3. PubMed ID: 23116217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.